ArticleMedicine2026
The role of total vaginal hysterectomy versus total abdominal hysterectomy in surgical management of uterine myomas: A retrospective single center cohort study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Total vaginal hysterectomy (TVH) has been performed even for enlarged uterine myoma, but it is regarded as more inferior than total abdominal hysterectomy (TAH). The aim of this study was to compare the role of surgical choice in patients undergoing either TVH or TAH for uterine myoma. In this retrospective cohort study, 140 hysterectomies with bilateral adnexectomy were planned for postmenopausal women with uterine myoma between 2020 and 2024, in a tertiary center hospital. The diagnosis was established after clinical symptomatology and transvaginal ultrasound, with histopathological confirmation obtained postoperatively. The patients were divided into 2 groups: the TVH group (n = 70) and the TAH group (n = 70). Patient features such as age, uterine weight, body mass index (BMI), parity, operative time, intraoperative blood loss, hospital stay, medical history, surgical history, intra and postoperative complications, and adhesions were assessed. Mean age, uterine weight, BMI, and parity showed no significant difference between the groups. Instead, the TVH group was linked with significantly shorter operative time, lower intraoperative blood loss, and reduced hospital stay compared to the TAH group (P < .001). However, there were more medical and surgical histories in patients from the TAH group compared with the TVH group, including postoperative complications (11.44% vs 4.29%) and adhesions (32.86% vs 20%). In most cases, uterine hemisection, tactical myomectomy, or morcellation were used in order to reduce uterine size for the TVH group (78.57%). Our findings sustain that shorter operating time, lower intraoperative blood loss, and reduced hospital stay recommend TVH as a suitable choice in carefully selected postmenopausal women with enlarged uterine myoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.